Gastric neuroendocrine tumor treated with endoscopic submucosal dissection

Pawel Bojar; Jaroslaw Swatek; Jaroslaw Drabko; Katarzyna Golec; Anna Ostrowska; Justyna Szumilo

doi:10.1515/cipms-2016-0037

.blurhash-client-img { display: none !important; }

Gastric neuroendocrine tumor treated with endoscopic submucosal dissection

Current Issues in Pharmacy and Medical Sciences

Volume 29 (2016): Issue 4 (December 2016)

By: Pawel Bojar, Jaroslaw Swatek, Jaroslaw Drabko, Katarzyna Golec, Anna Ostrowska and Justyna Szumilo

Open Access

|Jan 2017

Read online

Abstract

A case of a 59-year-old male patient with gastric neuroendocrine tumor which was misdiagnosed as adenocarcinoma, is presented. Herein, primary diagnosis was made due to the similarity of endoscopic pictures of both diseases and dues to the inappropriate interpretation of a small biopsy sample. The patient was qualified for endoscopic submucosal dissection. Microscopic examination of whole lesion, supplemented by immmunohistochemical reactions (chromogranin A, synaptophysin, cytokeratins 7 and 20, Ki67) revealed gastric neuroendocrine tumor (NET) G2.

The lesson learnt is that to provide effective treatment to the patient, it is necessary to use all available methods to make a proper diagnosis and to distinguish the suspected disease from others with similar features.

1. Bosman F.T., Carneiro, R., Hruban H., Theise N.D., editors (2010), WHO Classification of Tumours of the Digestive System 4^th ed., Lyon: The International Agency for Research on Cancer.
Search in Google Scholar Back to article
2. Cai Y.C. et al.: Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum.Pathol., 32, 10, 2001.10.1053/hupa.2001.2824511679943
Open DOI Search in Google Scholar Open in PubMed Back to article
3. Erim T., Colak Y., Szomstein S.: Gastric carcinoid tumor after laparoscopic sleeve gastrectomy., Surgery for Obesity and Related Diseases, Volume 11, Issue 6, 2015.10.1016/j.soard.2015.06.01626507937
Open DOI Search in Google Scholar Open in PubMed Back to article
4. Jianu C.S. et al.: Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment.Pharmacol. Ther., 36, 7, 2012.10.1111/apt.1201222861200
Open DOI Search in Google Scholar Open in PubMed Back to article
5. Kidd M., Gustafsson B., Modlin I.M.: Gastric carcinoids (neuroendocrine neoplasms). Gastroenterol.Clin. North. Am., 42, 2, 2013.
Search in Google Scholar Back to article
6. Kwon Y.H. et al.: Long-term follow up of endoscopic resection for type 3 gastric NET. World J.Gastroenterol., 19, 46, 2013.10.3748/wjg.v19.i46.8703387051724379589
Open DOI Search in Google Scholar Open in PubMed Back to article
7. Modlin I.M. et al.: Current status of gastrointestinal carcinoids. Gastroenterology. 128, 6, 2015.10.1053/j.gastro.2005.03.03815887161
Open DOI Search in Google Scholar Open in PubMed Back to article
8. Muehldorfer SM et al.: Multicenter Study Group “Gastric Polyps”. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut, 50, 4, 2002.10.1136/gut.50.4.465177318311889063
Open DOI Search in Google Scholar Open in PubMed Back to article
9. Park S.Y. et al.: Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol., 33, 11, 2002.10.1053/hupa.2002.12942212454811
Open DOI Search in Google Scholar Open in PubMed Back to article
10. Perryman S., Kaltenbach T., Eisenberg D.: Preoperative finding of gastric neuroendocrine tumor (gastric carcinoid) in a patient evaluated for bariatric surgery. Surgery for Obesity and Related Diseases, 7, 5, 2011.
Search in Google Scholar Back to article
11. Ramage J.K. et al.: UK and Ireland Neuroendocrine Tumour Society. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut, 61, 1, 2012.10.1136/gut.2004.053314186780115888809
Open DOI Search in Google Scholar Open in PubMed Back to article
12. Wang Z. et al.: Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms. Exp. Ther. Med., 10, 3, 2015.10.3892/etm.2015.2634453322026622444
Open DOI Search in Google Scholar Open in PubMed Back to article
13. Xu T.M. et al.: Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis. J. Dig. Dis., 17, 3, 2016.10.1111/1751-2980.1232626860897
Open DOI Search in Google Scholar Open in PubMed Back to article

Articles in this issue

DOI: https://doi.org/10.1515/cipms-2016-0037 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X

Journal RSS Feed

Language: English

Page range: 176 - 179

Submitted on: Jul 1, 2016

Accepted on: Aug 26, 2016

Published online: Jan 23, 2017

Published in print: Dec 1, 2016

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Keywords:

neuroendocrine tumor,

carcinoid,

endoscopic submucosal dissection,

stomach

Related subjects:

Medicine,

Clinical medicine,

Pharmacology, toxicology

© 2017 Pawel Bojar, Jaroslaw Swatek, Jaroslaw Drabko, Katarzyna Golec, Anna Ostrowska, Justyna Szumilo, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 29 (2016): Issue 4 (December 2016)